Henry Schein Cash Flow from Financial Activities 2012-2026 | HSIC
Henry Schein annual/quarterly cash flow from financial activities history and growth rate from 2012 to 2026. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- Henry Schein cash flow from financial activities for the quarter ending March 31, 2026 was $-0.188B, a 63.14% decline year-over-year.
- Henry Schein cash flow from financial activities for the twelve months ending March 31, 2026 was $64M, a 105.19% decline year-over-year.
- Henry Schein annual cash flow from financial activities for 2025 was $-0.188B, a 63.14% decline from 2024.
- Henry Schein annual cash flow from financial activities for 2024 was $-0.51B, a 172.75% decline from 2023.
- Henry Schein annual cash flow from financial activities for 2023 was $0.701B, a 322.54% decline from 2022.
|
Henry Schein Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2025 | $-188 |
| 2024 | $-510 |
| 2023 | $701 |
| 2022 | $-315 |
| 2021 | $-333 |
| 2020 | $-187 |
| 2019 | $-216 |
| 2018 | $-604 |
| 2017 | $-113 |
| 2016 | $-327 |
| 2015 | $-348 |
| 2014 | $-155 |
| 2013 | $-336 |
| 2012 | $-171 |
| 2011 | $-357 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $8.645B | $13.184B |
| Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |